<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:02:10Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10636009" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10636009</identifier>
        <datestamp>2023-11-11</datestamp>
        <setSpec>scirep</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
              <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
              <journal-title-group>
                <journal-title>Scientific Reports</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2045-2322</issn>
              <publisher>
                <publisher-name>Nature Publishing Group UK</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10636009</article-id>
              <article-id pub-id-type="pmcid">PMC10636009</article-id>
              <article-id pub-id-type="pmc-uid">10636009</article-id>
              <article-id pub-id-type="pmid">37945671</article-id>
              <article-id pub-id-type="pmid">37945671</article-id>
              <article-id pub-id-type="publisher-id">46490</article-id>
              <article-id pub-id-type="doi">10.1038/s41598-023-46490-5</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The metabolic effects of intermittent versus continuous feeding in critically ill patients</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wilkinson</surname>
                    <given-names>D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gallagher</surname>
                    <given-names>I. J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McNelly</surname>
                    <given-names>A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bear</surname>
                    <given-names>D. E.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hart</surname>
                    <given-names>N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Montgomery</surname>
                    <given-names>H. E.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff11">11</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Le Guennec</surname>
                    <given-names>A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff12">12</xref>
                  <xref ref-type="aff" rid="Aff13">13</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Conte</surname>
                    <given-names>M. R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff12">12</xref>
                  <xref ref-type="aff" rid="Aff13">13</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Francis</surname>
                    <given-names>T.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Harridge</surname>
                    <given-names>S. D. R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Atherton</surname>
                    <given-names>P. J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Puthucheary</surname>
                    <given-names>Z. A.</given-names>
                  </name>
                  <address>
                    <email>z.puthucheary@qmul.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                  <xref ref-type="aff" rid="Aff13">13</xref>
                  <xref ref-type="aff" rid="Aff14">14</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.4563.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8868</institution-id><institution>MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Metabolic and Molecular Physiology, </institution><institution>University of Nottingham, Queen’s Medical Cetnre, </institution></institution-wrap>Nottingham, UK </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.415598.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0641 4263</institution-id><institution>National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, </institution><institution>Nottinghan University Hospitals and University of Nottingham, Queen’s Medical Centre, </institution></institution-wrap>Nottingham, UK </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.413619.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0400 0219</institution-id><institution>School of Medicine, </institution><institution>University of Nottingham, Royal Derby Hospital, </institution></institution-wrap>Derby, UK </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045wgfr59</institution-id><institution-id institution-id-type="GRID">grid.11918.30</institution-id><institution-id institution-id-type="ISNI">0000 0001 2248 4331</institution-id><institution>University of Sterling, </institution></institution-wrap>Stirling, UK </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.4868.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 1133</institution-id><institution>William Harvey Research Institute, </institution><institution>Barts and The London School of Medicine and Dentistry, Queen Mary University of London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.451052.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0581 2008</institution-id><institution>Department of Nutrition and Dietetics St Thomas’ NHS Foundation Trust, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220mzb33</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Department of Critical Care, </institution><institution>Guy’s and St. Thomas’ NHS Foundation &amp; King’s College London (KCL) NIHR BRC, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220mzb33</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Centre for Human and Applied Physiological Science, </institution><institution>King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00j161312</institution-id><institution-id institution-id-type="GRID">grid.420545.2</institution-id><institution>Lane Fox Respiratory Service, </institution><institution>Guy’s &amp; St Thomas’ Foundation Trust, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220mzb33</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Lane Fox Clinical Respiratory Physiology Research Centre, Kings College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02jx3x895</institution-id><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 1201</institution-id><institution>Department of Medicine and Centre for Human Health and Performance, </institution><institution>University College London (UCL), </institution></institution-wrap>London, UK </aff>
                <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220mzb33</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Centre for Biomolecular Spectroscopy, Guy’s Campus, </institution><institution>King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220mzb33</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Randall Centre for Cell and Molecular Biophysics, Guy’s Campus, </institution><institution>King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/019my5047</institution-id><institution-id institution-id-type="GRID">grid.416041.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0738 5466</institution-id><institution>Adult Critical Care Unit, </institution><institution>Royal London Hospital, </institution></institution-wrap>Whitechapel, London, E1 1BB UK </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>9</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>9</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>13</volume>
              <elocation-id>19508</elocation-id>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>4</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>1</day>
                  <month>11</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2023</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">Intermittent (or bolus) feeding regimens in critically ill patients have been of increasing interest to clinicians and scientists. Changes in amino acid, fat and carbohydrate metabolites over time might yet deliver other benefits (e.g. modulation of the circadian rhythm and sleep, and impacts on ghrelin secretion, insulin resistance and autophagy). We set out to characterise these changes in metabolite concentration. The Intermittent versus Continuous Feeding in Critically Ill paitents study (NCT02358512) was an eight-centre single-blinded randomised controlled trial. Patients were randomised to received a continuous (control arm) or intermittent (6x/day, intervention arm) enteral feeding regimen. Blood samples were taken on trial days 1, 7 and 10 immediately before and 30 min after intermittent feeds, and at equivalent timepoints in the control arm. A pre-planned targeted metabolomic analysis was performend using Nuclear Resonance Spectroscopy. Five hundred and ninety four samples were analysed from 75 patients. A total of 24 amino acid-, 19 lipid based-, and 44 small molecule metabolite features. Across the main two axes of variation (40–60% and 6–8% of variance), no broad patterns distinguished between intermittent or continuous feeding arms, across intra-day sampling times or over the 10 days from initial ICU admission. Logfold decreases in abundance were seen in metabolites related to amino acids (Glutamine − 0.682; Alanine − 0.594), ketone body metabolism (Acetone − 0.64; 3-Hydroxybutyric Acid − 0.632; Acetonacetic Acid − 0.586), fatty acid (carnitine − 0.509) and carbohydrate metabolism ( Maltose − 0.510; Citric Acid − 0.485). 2–3 Butanediol, a by-product of sugar-fermenting microbial metabolism also decreased (− 0.489). No correlation was seen with change in quadriceps muscle mass for any of the 20 metabolites varying with time (all <italic>p</italic> &gt; 0.05). Increasing severity of organ failure was related to increasing ketone body metabolism (3 Hydroxybutyric Acid-1 and − 3; <italic>p</italic> = 0.056 and <italic>p</italic> = 0.014), carnitine deficiency (<italic>p</italic> = 0.002) and alanine abundancy (<italic>p</italic> − 0.005). A 6-times a day intermittent feeding regimen did not alter metabolite patterns across time compared to continuous feeding in critically ill patients, either within a 24 h period or across 10 days of intervention. Future research on intermittent feeding regimens should focus on clinical process benefits, or extended gut rest and fasting.</p>
              </abstract>
              <kwd-group kwd-group-type="npg-subject">
                <title>Subject terms</title>
                <kwd>Clinical trial design</kwd>
                <kwd>Translational research</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>National Institute of Health Research’s Comprehensive Biomedical Research Centre at University College London Hospitals</institution>
                  </funding-source>
                  <award-id>BRC202 rev/CM/AM/101320; RCF236/AMcN/2015</award-id>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>J P Moulton Charitable Foundation</institution>
                  </funding-source>
                  <award-id>JM29/04/ 14; JM02/06/15</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>McNelly</surname>
                      <given-names>A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>Intensive Care Foundation, UK</institution>
                  </funding-source>
                  <award-id>New Investigator Award, A. S. McN.</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>McNelly</surname>
                      <given-names>A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>North Thames Local Clinical Research Network</institution>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>London South Local Clinical Research Network</institution>
                  </funding-source>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>American Society of Parenteral and Enteral Nutrition Rhoads Research Foundation</institution>
                  </funding-source>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© Springer Nature Limited 2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction</title>
              <p id="Par3">Intermittent or bolus enteral feeding regimens in critically ill patients have been of increasing interest to clinicians and scientists<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The alternative, continuous feeding, is associated with a variety of physiological and metabolic effects that may be detrimental to patients.</p>
              <p id="Par4">Critically ill patients lose 2–3% of muscle mass each day as a result of decreased muscle protein synthesis and unchecked protein breakdown<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. In healthy subjects, sustained elevated circulating amino acid concentrations due to continuous feeding results in the “muscle full effect”, whereby the protein synthetic response becomes refractory after about 90 min, despite availability of amino acids<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. In our recent multi-centre single blinded randomised controlled trial, no difference in muscle mass loss was identified between critically ill patients in multi-organ failure randomised to continuous enteral feeding, when compared to those receiving an intermittent feeding regimen<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p>
              <p id="Par5">However, it has been speculated that other less well-explored benefits of intermittent feeding might improve patient outcome or experience<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Continuous feeding may contribute to circadian rhythm misalignment, affecting not only metabolism<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, but also sleep quality (and hence susceptibility to delirium, pain and detrimental cognitive outcomes; and engagement with rehabilitation<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Continuous feeding attenuates both Ghrelin and peptide YY diurnal variation with pleiotropic metabolic effects<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, and increases insulin resistance via inhibition of glucose transport<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> while also impacting important cellular processes (e.g. inhibiting autophagy which leads to an accumulation of end-products of cellular damage, potentially impeding overall patient recovery<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>).</p>
              <p id="Par6">We hypothesise that intermittent enteral feeding may modulate amino acid, fat and carbohydrate metabolite profiles over time, when compared to continuous feeding. For example, alterations in amino acid trafficking may be advantageous as a result of addressing the muscle full effect, providing support for future trials combining intermittent feeding with a co-intervention addressing bioenergetics failure to improve physical function<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. Decreasing nocturnal carbohydrate and lipid delivery may improve circadian rhythm quality by reducing the dissociation between central (e.g. suprachiasmatic nuclei) timing mechanisms and nutritional stimuli<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. Time epochs without nutrition delivery promote autophagy, advantageously removing cellular debris (e.g. from myonecrosis) which would be reflected in amino acid metabolite abundance<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. We sought to charcterise these changes in plasma metabolite profile through a Nuclear Magnetic Resonance (NMR) based analysis in order to inform the design of future nutritional trials in this population<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Study design and participants</title>
                <p id="Par7">The Intermittent versus Continuous Feeding in critically ill patients study (IVC study, NCT02358512) was a multicentre single-blinded randomised controlled trial performed on 8 UK intensive care units (ICU), in which adult (≥ 18 years of age) patients were randomised (1:1 ratio, concealed allocation) to receive either a continuous or intermittent enteral feeding regimen5.Chest. 158:183–194. The original study received ethics committee approval (National Research Ethics Service Committee London-Queens Square; REC reference 14/LO/1792; IRAS project ID 160,281) and was registered on clinicaltrials.gov before randomisation was commenced (05/11/15). All research was performed in accordance with the Declaration of Helsinki. Prospective informed assent was obtained in writing from a nominated personal consultee or professional consultee. Retrospective participant consent was obtained on return of participant’s mental capacity. Permission to use participants’ data if capacity did not return or they did not survive was included in the assent process.</p>
              </sec>
              <sec id="Sec4">
                <title>A pre-planned targeted metabolomic cohort ancillary study was performed</title>
                <p id="Par8">In brief, patients were required to have been admitted to the ICU for ≤ 24 h prior to enrolment. Included patients were those anticipated to be mechanically ventilated for &gt; 48 h, who required enteral feeding via a nasogastric tube, had multi-organ failure (Sequential Organ Failure Assessment (SOFA) score &gt; 2 in ≥ 2 domains at admission), had a likely ICU stay of &gt; 7 days, and who were considered likely to survive &gt; 10 days. The characteristics and demographics of patients randomised to each limb were well balanced.</p>
              </sec>
              <sec id="Sec5">
                <title>Study procedures</title>
                <p id="Par9">On recruitment, patient age, weight, medical history and APACHE II and SOFA score on admission to ICU, were recorded. Daily nutritional and biochemical data for the 10 day intervention (including volume of enteral feed received, energy and protein targets, urea and creatinine levels), and requirement for renal replacement therapy, were documented.</p>
                <p id="Par10"><italic>Exposure:</italic> The intermittent feeding regimen (the intervention) consisted of six feeds per 24 h, each administered over 3 to 5 min via nasogastric tube.</p>
                <p id="Par11"><italic>Comparator</italic>: The continuous (standard) feeding regimen was delivered continuously over 24 h, as per local guidelines.</p>
                <p id="Par12">More details on the feeding regimens can be found in the original publication and supplement<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p>
              </sec>
              <sec id="Sec6">
                <title>Sample collection</title>
                <p id="Par13">Blood samples were collected in heparinised tubes and the supernatant was removed and frozen at − 80 <sup>O</sup>C post centrifugation. This occurred twice a day, at the 9 a.m. and 1 p.m. feeds in the intermittent arm. In the continuous feeding arm, blood samples were taken 30 min apart at 9 a.m. and 1 p.m.. These samples were collected as part of the original trial<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Samples were collected on days 1 7 and 10, based around our previous observational study<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. However manpower constraints prevented operationalisation of day 3 sampling.</p>
              </sec>
              <sec id="Sec7">
                <title>Measures of muscle mass</title>
                <p id="Par14">Rectus Femoris Cross-Sectional Area (RFCSA) was measured at randomisation (as baseline) and at day 10 (primary outcome of the original trial)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. RFCSA is a validated measure that is increasingly used to measure muscle mass in the critically ill<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>.</p>
              </sec>
              <sec id="Sec8">
                <title>Metabolite analysis</title>
                <p id="Par15">Blood samples were analysed using a targeted metabolomics approach using Nuclear Magnetic Resonance Spectroscopy (NMR). For each sample, 300 μL of plasma was mixed with 300 μL of a 90/10 H<sub>2</sub>O/D<sub>2</sub>O phosphate buffer at pH 7.4, containing 0.4 mM of NaN<sub>3</sub> and 0.03 mM TSP, and transferred to 5 mm NMR tubes. NMR experiments were recorded on a Bruker 600 MHz NMR spectrometer equipped with a Prodigy cryoprobe. On each sample, a T<sub>2</sub>-filtered <sup>1</sup>H NMR spectrum and a diffusion-filtered <sup>1</sup>H NMR spectrum were acquired, to analyse small molecules and lipoproteins separately, respectively. The T<sub>2</sub>-filtered spectrum was acquired using the PROJECT pulse sequence<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, with 4 dummy scans, 64 scans, a spectral width of 20.82 ppm, an inter-scan delay of 4 s and an acquisition time of 2.62 s. The diffusion-filtered spectrum was acquired with a pulse sequence using stimulated echoes and LED, along with bipolar gradients and spoil gradients<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, with 4 dummy scans, 64 scans, a spectral width of 20.82 ppm, a diffusion time of 120 ms, a gradient length of 1.375 ms for the bipolar gradients, an inter-scan delay of 4 s and an acquisition time of 2.62 s. Each spectra was referenced using the TSP peak at 0.00 ppm.</p>
              </sec>
              <sec id="Sec9">
                <title>2D NMR spectra for metabolites identification</title>
                <p id="Par16">For metabolite identification, 2D NMR spectra were acquired on one of the samples, in particular [<sup>1</sup>H, <sup>1</sup>H]-TOCSY and [<sup>1</sup>H,<sup>13</sup>C] HSQC. For the [<sup>1</sup>H,<sup>1</sup>H]-TOCSY, the Bruker pulse sequence “dipsi2gpphzs” was used, slightly modified to include presaturation, with 16 scans, 512 t1 increments, a spectral width of 13.7 ppm in both dimensions and a relaxation delay of 2 s. The [<sup>1</sup>H,<sup>13</sup>C]-HSQC spectrum was acquired using the Bruker pulse sequence “hsqcetgpsisp2.2”, with 32 scans, 512 t1 increments, a spectral width of 210 ppm and 20.8 ppm in the <sup>13</sup>C and <sup>1</sup>H dimension respectively, and a relaxation time of 2 s. Once acquired, libraries including HMDB<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and BMRB<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> were used to annotate the 2D spectra and, by extension, the 1D spectra.</p>
              </sec>
              <sec id="Sec10">
                <title>Sample size estimate</title>
                <p id="Par17">This was an exploratory study of the metabolome under different feeding regimes in critically ill patients. Without pilot data existing power calculation packages e.g. Metaboanalyst ((<ext-link ext-link-type="uri" xlink:href="https://www.metaboanalyst.ca">https://www.metaboanalyst.ca</ext-link>) are unable to estimate the effect size distribution, the average power and the minimal sample size<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>. These 75 subjects represent those patients in whom sampling was performed, as opposed to a pre-specified sample size.</p>
              </sec>
              <sec id="Sec11">
                <title>Statistical analysis</title>
                <p id="Par18">The statistical analyses were performed using R version 4.0.3 (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/">https://cran.r-project.org/</ext-link>) and R Studio (version 1.3.1093). All R scripts were written in house and can be accessed at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.10055412">https://doi.org/10.5281/zenodo.10055412</ext-link>.</p>
                <p id="Par19">Following NMR analyses, separate data matrices of metabolite abundances for lipid species, small molecule species and amino acids were generated and each analysed separately as targeted panels of metabolites. Each metabolite panel was first filtered to remove missing data points and/or those with negative abundance values, followed by log transformation, centering and scaling to bring metabolite abundances within the same dynamic range. Exploratory visualisations were then generated using principal component analyses to assess for any obvious effects of the feeding regimens on metabolite abundances. To determine differences in metabolite abundance between feeding regimens, across time and interactions between feed and time, analyses were performed using a moderated empirical Bayesian mixed effects model approach with the limma (version 3.18) R package, with the primary outcome being a difference in metabolite profiles between arms<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. This approach ‘borrows’ information on variance in the data to moderate t-statistics in individual comparisons and is more conservative than unmoderated t-tests. Where significant main effects were observed, these were followed up utilising specific contrasts to determine where these effects were being observed within the experimental model. For each comparison, false discovery rate (FDR) correction was applied using the Benjamini–Hochberg approach (q value threshold of 0.05). Significant metabolites were then assessed for their relationship to clinical outcome measures; change in rectus femoris muscle cross sectional area (CSA) and admission Sequencial Organ Failure Assessment (SOFA) Score, where data were available for all patients. Simple linear regression was performed between the significant scaled and transformed metabolite abundances and clinical endpoints to investigate associations. All graphical representations were generated using ggplot2 (version 3.4) from the tidyverse<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p>
                <p id="Par20">Linear mixed effect modelling was chosen over standard statistical approaches (e.g. repeated measures ANOVA) as it deals better with designs where the repeated measure is continuous (i.e. in this case, time), where the design may become unbalanced (e.g. due to attrition) and where non-independence of data due to clustering within individuals exists, as is likely to be the case here. In addition we used limma to generate empirical Bayes estimates of metabolite-wise variance<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. These variance estimates are shrunk towards a common variance estimate generated by ‘borrowing information’ from all metabolites. This is a form of regularisation in the model fitting and is conservative in the context of small numbers<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p>
              </sec>
              <sec id="Sec12">
                <title>Ethical approval</title>
                <p id="Par21">The study received ethics committee approval (National Research Ethics Service Committee London-Queens Square; REC reference 14/LO/1792; IRAS project ID 160,281) and was registered on clinicaltrials.gov before randomisation was commenced.</p>
              </sec>
            </sec>
            <sec id="Sec13">
              <title>Results</title>
              <p id="Par22">Of the 121 patients randomised, 62 were in the intervention feeding (IF) group, and 59 in the control feeding (CF) group. Five hundred and ninety four samples were available for 75 patients (Table <xref rid="Tab1" ref-type="table">1</xref>), with sampling timepoint breakdown available in Table <xref rid="MOESM1" ref-type="media">S1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the 75 patients whose metabolome abundances are described. LOS = Length of Stay; APACHE II = Acute Physiology and Chronic Health Evaluation Score; SOFA = Sequentional Organ Failure Assessment; RRT = Renal Replacement Therapy; NMBA = Neuromuscular Blockade administration. Data are mean (95% confidence intervals), except for # indicating median with range.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Intermittent Feeding (n = 40)</th><th align="left">Continuous Feeding (n = 35)</th></tr></thead><tbody><tr><td align="left">Age, y</td><td align="left">55(50.0–60.0)</td><td align="left">61 (55–67)</td></tr><tr><td align="left">Male, No. (%) ¥</td><td align="left">11 (27.5)</td><td align="left">9 (25.7)</td></tr><tr><td align="left">LOS prior to ICU admission, d <sup>#</sup></td><td align="left">0.0 (0–15)</td><td align="left">0.0 (0–13)</td></tr><tr><td align="left">Period ventilated, d <sup>#</sup></td><td align="left">11 (2–48)</td><td align="left">8 (2–41)</td></tr><tr><td align="left">ICU LOS, d<sup>#</sup></td><td align="left">16 (3–93)</td><td align="left">17 (3–52)</td></tr><tr><td align="left">Hospital LOS, d<sup>#</sup></td><td align="left">27 (4–183)</td><td align="left">32 (4–102)</td></tr><tr><td align="left">APACHE II score</td><td align="left">21 (19–24)</td><td align="left">20 (17–22)</td></tr><tr><td align="left">SOFA score on admission</td><td align="left">10 (9–11)</td><td align="left">11 (10–12)</td></tr><tr><td align="left">ICU survival, No. (%)</td><td align="left">28 (70)</td><td align="left">29 (83)</td></tr><tr><td align="left">Hospital survival, No. (%)</td><td align="left">21 (52.5)</td><td align="left">28 (80)</td></tr><tr><td align="left">RRT, No. (%)</td><td align="left">16 (40)</td><td align="left">12 (34)</td></tr><tr><td align="left">NMBA use, d<sup>#</sup></td><td align="left">0 (0–8)</td><td align="left">1 (0–6)</td></tr><tr><td align="left">Hydrocortisone dose, mg total by day 10</td><td align="left">0 (0–2700)</td><td align="left">0 (0–3200)</td></tr><tr><td align="left">Gastro-protection, d<sup>#</sup></td><td align="left">9 (0–11)</td><td align="left">10 (0–11)</td></tr><tr><td align="left">Vasopressors support, d<sup>#</sup></td><td align="left">4 (0–11)</td><td align="left">5 (0–22)</td></tr><tr><td align="left">Sedation use, d<sup>#</sup></td><td align="left">7 (2–11)</td><td align="left">6 (0–11)</td></tr><tr><td align="left">Propofol dose by day 10, g</td><td align="left">21.1 (15.2–27.1)</td><td align="left">23.0 (16.4–29.5)</td></tr><tr><td align="left" colspan="3">Admission diagnosis, No. (%)</td></tr><tr><td align="left"> Sepsis</td><td align="left">13 (32.5)</td><td align="left">14 (40)</td></tr><tr><td align="left"> Cardiogenic shock</td><td align="left">9 (22.5)</td><td align="left">8 (22.9)</td></tr><tr><td align="left"> Trauma</td><td align="left">5 (12.5)</td><td align="left">7 (20.0)</td></tr><tr><td align="left"> Respiratory failure</td><td align="left">5 (12.5)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Intracranial haemorrhage</td><td align="left">2 (5.0)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Acute liver failure</td><td align="left">2 (5.0)</td><td align="left">2 (5.7)</td></tr><tr><td align="left"> Acute kidney Injury</td><td align="left">2 (5.0)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Drug overdose</td><td align="left">1 (2.5)</td><td align="left">0 (0.0)</td></tr><tr><td align="left"> Emergency surgery</td><td align="left">1 (2.5)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Cerebrovascular accident</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr><tr><td align="left" colspan="3">Comorbidities, No. (%)</td></tr><tr><td align="left"> Hypertension</td><td align="left">9 (22.5)</td><td align="left">4 (11.4)</td></tr><tr><td align="left"> Chronic respiratory diseases</td><td align="left">9 (22.5)</td><td align="left">11 (31.4)</td></tr><tr><td align="left"> Diabetes Mellitus</td><td align="left">8(20.0)</td><td align="left">7 (20.0)</td></tr><tr><td align="left"> Ischemic heart disease</td><td align="left">8 (20.0)</td><td align="left">10 (28.6)</td></tr><tr><td align="left"> Psychiatric diseases</td><td align="left">6 (15.0)</td><td align="left">5(14.3)</td></tr><tr><td align="left"> Renal impairment</td><td align="left">2 (5.0)</td><td align="left">5 (14.3)</td></tr><tr><td align="left"> Obesity</td><td align="left">4 (10.0)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Liver cirrhosis</td><td align="left">3 (7.5)</td><td align="left">3 (8.6)</td></tr><tr><td align="left"> Haem-oncological disease</td><td align="left">3 (7.5)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Thyroid disease</td><td align="left">2 (5.0)</td><td align="left">0 (0.0)</td></tr><tr><td align="left"> Crohn’s disease</td><td align="left">0 (0.0)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Previous CVA</td><td align="left">1 (2.5)</td><td align="left">1 (2.9)</td></tr><tr><td align="left"> Chronic Pancreatitis</td><td align="left">1 (2.5)</td><td align="left">0 (0.0)</td></tr></tbody></table></table-wrap></p>
              <p id="Par23">Plasma metabolomic analyses using NMR identified a total of twenty-four amino acid metabolite features, nineteen lipid based metabolite features and forty-four other small molecule metabolite features across five hundred and ninety observations/samples (Figs. <xref rid="MOESM1" ref-type="media">S1</xref> and <xref rid="MOESM1" ref-type="media">S2</xref>). Four samples were removed from the final analyses due to missing data points, or poor quality data output (e.g. negative abundance). Each of these individual metabolite panels were then taken forward for further analyses.</p>
              <sec id="Sec14">
                <title>Exploratory visualisations</title>
                <p id="Par24">We first examined the metabolite panels for broad patterns of variability that might underpin physiologically relevant changes as a result of feeding regimen; time since admission or time of day. Although a few observations from each panel were clustering out with others, along the main two axes of variation (PC1—explaining between 40 and 60% of variance and PC2—explaining 6 and 8% of variance) no broad patterns distinguished between intermittent or continuous feeding arms, across intra-day sampling times or over the 10 days from initial ICU admission (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A–C).<fig id="Fig1"><label>Figure 1</label><caption><p>(<bold>A</bold>–<bold>C</bold>) Principal Component Analyses of; (<bold>A</bold>) Amino Acid Metabolites, (<bold>B</bold>) Lipid Metabolites and (<bold>C</bold>) Small Molecule Metabolites to assess for patterns of variability that might underpin physiological changes due to time of day (top graph in panel), time since admission (middle graph in panel) and feeding regimen (bottom graph in each panel).</p></caption><graphic xlink:href="41598_2023_46490_Fig1_HTML" id="MO1"/></fig></p>
              </sec>
              <sec id="Sec15">
                <title>Specific metabolite alterations</title>
                <p id="Par25">We next addressed the question of specific metabolite alterations between the feeding arms using a mixed effect moderated empirical Bayesian approach<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Comparison of feeding arms revealed no statistically significant abundance differences after FDR correction for multiple testing (data not shown) between arms at individual sampling times. Data were therefore collapsed across feeding arms and sampling times and examined for an effect of duration of ICU stay using the first sample collected on each day. After FDR correction for multiple testing no lipid based molecules, and only two amino acids (glutamine and alanine), decreased in abundance over the 0–10 day period. Several other small molecules (see Table <xref rid="Tab2" ref-type="table">2</xref>) also decreased in abundance over this period, with no variation seen across the earlier time points (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A–C and Supplementary Fig. <xref rid="MOESM1" ref-type="media">S3</xref>). Putative identification of these metabolites showed a signature related to metabolites involved with ketone body metabolism, energy/nutrient metabolism and amino acid metabolism (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of all metabolites and associated Human Metabolite Database (HMDB) ID number and related biological pathway whose concentration was found to change significantly over the duration of ICU stay, following removal of a non-significant feeding arm effect by collapsing data into a single dataset together with their associated Human Metabolite Database (HMDB) ID number and related biological pathway. Where two peaks of the same metabolites are seen (representing different isomers) these are numbered separately. “Unknown” refers to metabolites not seen in the HMDB.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Metabolite</th><th align="left">log fold change abundance</th><th align="left">t Statistic</th><th align="left"><italic>p</italic> value</th><th align="left">FDR Corrected <italic>p</italic> value</th><th align="left">HMDB number</th><th align="left">Metabolic pathway</th></tr></thead><tbody><tr><td align="left">Dimethylsulfone</td><td char="." align="char"> − 0.6842</td><td char="." align="char"> − 3.7749</td><td char="." align="char">0.0002</td><td char="." align="char">0.0099</td><td align="left">HMDB0004983</td><td align="left">Sulphur Metabolism</td></tr><tr><td align="left">Acetone</td><td char="." align="char"> − 0.6369</td><td char="." align="char"> − 3.5741</td><td char="." align="char">0.0005</td><td char="." align="char">0.0102</td><td align="left">HMDB0001659</td><td align="left">Ketone Body Metabolism</td></tr><tr><td align="left">Lactic acid</td><td char="." align="char"> − 0.6338</td><td char="." align="char"> − 3.4274</td><td char="." align="char">0.0008</td><td char="." align="char">0.0113</td><td align="left">HMDB0000190</td><td align="left">Gluconeogenesis/Pyruvate Metabolism</td></tr><tr><td align="left">3-Hydroxybutyric Acid 2</td><td char="." align="char"> − 0.6322</td><td char="." align="char"> − 3.2916</td><td char="." align="char">0.0012</td><td char="." align="char">0.0134</td><td align="left">HMDB0000442</td><td align="left">Ketone Body Metabolism</td></tr><tr><td align="left">3-Hydroxybutyric Acid 1</td><td char="." align="char"> − 0.6082</td><td char="." align="char"> − 3.2042</td><td char="." align="char">0.0016</td><td char="." align="char">0.0143</td><td align="left">HMDB0000442</td><td align="left">Ketone Body Metabolism</td></tr><tr><td align="left">Acetonacetic Acid</td><td char="." align="char"> − 0.5863</td><td char="." align="char">3.0174</td><td char="." align="char">0.0030</td><td char="." align="char">0.0217</td><td align="left">HMDB0304256</td><td align="left">Ketone Body Metabolism</td></tr><tr><td align="left">Unknown 6</td><td char="." align="char"> − 0.5750</td><td char="." align="char"> − 2.9628</td><td char="." align="char">0.0035</td><td char="." align="char">0.0220</td><td align="left">Unknown</td><td align="left">Unknown</td></tr><tr><td align="left">Carnitine</td><td char="." align="char"> − 0.5087</td><td char="." align="char"> − 2.8732</td><td char="." align="char">0.0046</td><td char="." align="char">0.0253</td><td align="left">HMDB0000062</td><td align="left">Fatty Acid metabolism</td></tr><tr><td align="left">Pyroglutamic acid</td><td char="." align="char"> − 0.5254</td><td char="." align="char"> − 2.7728</td><td char="." align="char">0.0062</td><td char="." align="char">0.0303</td><td align="left">HMDB0000267</td><td align="left">Amino Acid Metabolism</td></tr><tr><td align="left">Maltose</td><td char="." align="char"> − 0.5096</td><td char="." align="char"> − 2.6715</td><td char="." align="char">0.0083</td><td char="." align="char">0.0334</td><td align="left">HMDB0000163</td><td align="left">Starch and Sucrose Metabolism</td></tr><tr><td align="left">Myo-inositol</td><td char="." align="char"> − 0.4809</td><td char="." align="char"> − 2.6043</td><td char="." align="char">0.0101</td><td char="." align="char">0.0334</td><td align="left">HMDB0000211</td><td align="left">Galactose/Inositol Metabolism</td></tr><tr><td align="left">Pyridoxine</td><td char="." align="char"> − 0.6603</td><td char="." align="char"> − 2.5944</td><td char="." align="char">0.0103</td><td char="." align="char">0.0334</td><td align="left">HMDB0000239</td><td align="left">Vitamin B6 Metabolism</td></tr><tr><td align="left">3,4-Dihydroxybenzoic acid</td><td char="." align="char"> − 0.4918</td><td char="." align="char"> − 2.5793</td><td char="." align="char">0.0108</td><td char="." align="char">0.0334</td><td align="left">HMDB0001856</td><td align="left">Hydroxybenzoic Acid Derivatives</td></tr><tr><td align="left">Citric Acid 2</td><td char="." align="char"> − 0.4851</td><td char="." align="char"> − 2.5469</td><td char="." align="char">0.0118</td><td char="." align="char">0.0334</td><td align="left">HMDB0000094</td><td align="left">Energy Metabolism/TCA Cycle</td></tr><tr><td align="left">2,3-Butandiol</td><td char="." align="char"> − 0.4888</td><td char="." align="char"> − 2.5452</td><td char="." align="char">0.0119</td><td char="." align="char">0.0334</td><td align="left">HMDB0003156</td><td align="left">Microbiome Metabolism</td></tr><tr><td align="left">Citric Acid 4</td><td char="." align="char"> − 0.5101</td><td char="." align="char"> − 2.5361</td><td char="." align="char">0.0122</td><td char="." align="char">0.0334</td><td align="left">HMDB0000094</td><td align="left">Energy Metabolism/TCA Cycle</td></tr><tr><td align="left">Methanol</td><td char="." align="char"> − 0.4468</td><td char="." align="char"> − 2.3665</td><td char="." align="char">0.0191</td><td char="." align="char">0.0495</td><td align="left">HMDB0001875</td><td align="left">Primary Alcohol Metabolism</td></tr><tr><td align="left">Glutamine</td><td char="." align="char"> − 0.6828</td><td char="." align="char"> − 3.4989</td><td char="." align="char">0.0006</td><td char="." align="char">0.0135</td><td align="left">HMDB0000641</td><td align="left">Amino Acid Metabolism</td></tr><tr><td align="left">Alanine 2</td><td char="." align="char"> − 0.5938</td><td char="." align="char"> − 3.0605</td><td char="." align="char">0.0025</td><td char="." align="char">0.0293</td><td align="left">HMDB0000161</td><td align="left">Amino Acid Metabolism</td></tr><tr><td align="left">Alanine</td><td char="." align="char"> − 0.5407</td><td char="." align="char"> − 2.7981</td><td char="." align="char">0.0057</td><td char="." align="char">0.0437</td><td align="left">HMDB0000162</td><td align="left">Amino Acid Metabolism</td></tr></tbody></table></table-wrap><fig id="Fig2"><label>Figure 2</label><caption><p>(<bold>A</bold>–<bold>C</bold>) Volcano Plots depicting numbers of metabolites whose abundance altered over time, independent of feeding regimen across length of ICU admission for; (<bold>A</bold>) Amino Acid Metabolites, (<bold>B</bold>) Small Molecule Metabolites and (<bold>C</bold>) Lipid Metabolites. Vertical and horizontal cutoffs represent -log10 False Discovery Rate corrected p value and log fold change respectively, with differences from day 10 to day 1 presented in the left hand panel, differences from day 10 to day 7 in the middle panel and differences from day 7 to day 1 in the right hand panel. Four possible outcomes are presented; NS = Non-significant, FC =  &gt; than log fold change cut off (0.5) ; <italic>p</italic>-val = FDR corrected significant change and <italic>p</italic>-val and FC = FDR corrected significant change and &gt; log fold change cut off.</p></caption><graphic xlink:href="41598_2023_46490_Fig2_HTML" id="MO2"/></fig></p>
              </sec>
              <sec id="Sec16">
                <title>Clinical correlates</title>
                <p id="Par26">Finally, to assess whether there was any relationship between these groups of metabolites and clinical outcome following ICU admission, we used linear regression analysis to examine the relationship between the 20 metabolites varying over time and the primary clinical endpoint of change in muscle mass during admission (restricted to only n = 35 for this analyses due to need for complete data sets for all at 0 and 10 days). Patients in this cohort had a mean RF<sub>CSA</sub> of 455.4 cm<sup>2</sup> (95%CI 386.3–524.6) on admission and lost 17.6% (95%CI − 22.1% to − 14.2%) of muscle mass over the 10 day study period. No significant relationship was found (all <italic>p</italic> &gt; 0.05; Table <xref rid="Tab3" ref-type="table">3</xref> and supplementary data Fig. <xref rid="MOESM1" ref-type="media">S4</xref>). Weak relationships were seen between baseline abundance of significantly changing metabolites and organ failure scoring (see Table <xref rid="Tab4" ref-type="table">4</xref> and supplementary Fig. <xref rid="MOESM1" ref-type="media">S5</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Summary of Linear Regression Analyses of relationship between significantly changing metabolites and change in muscle cross sectional area over 10 day ICU stay. Where two peaks of the same metabolites are seen (representing different isomers) these are numbered separately. “Unknown” refers to metabolites not seen in the HMDB.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Metabolite</th><th align="left">R Squared</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Acetone</td><td char="." align="char">0.0032</td><td char="." align="char">0.7520</td></tr><tr><td align="left">Acetonacetic acid</td><td char="." align="char">0.0691</td><td char="." align="char">0.1331</td></tr><tr><td align="left">3-Hydroxybutyric</td><td char="." align="char">0.0418</td><td char="." align="char">0.2461</td></tr><tr><td align="left">3-Hydroxybutyric</td><td char="." align="char">0.0582</td><td char="." align="char">0.1692</td></tr><tr><td align="left">Unknown 6</td><td char="." align="char">0.0381</td><td char="." align="char">0.2684</td></tr><tr><td align="left">Citric acid 2</td><td char="." align="char">0.0007</td><td char="." align="char">0.8849</td></tr><tr><td align="left">Citric acid 4</td><td char="." align="char">0.0276</td><td char="." align="char">0.3296</td></tr><tr><td align="left">Dimethylsulfone</td><td char="." align="char">0.0357</td><td char="." align="char">0.3479</td></tr><tr><td align="left">Carnitine</td><td char="." align="char">0.0032</td><td char="." align="char">0.2846</td></tr><tr><td align="left">Methanol</td><td char="." align="char">0.0263</td><td char="." align="char">0.3591</td></tr><tr><td align="left">2,3-Butandiol</td><td char="." align="char">0.0297</td><td char="." align="char">0.3294</td></tr><tr><td align="left">Maltose</td><td char="." align="char">0.0157</td><td char="." align="char">0.4803</td></tr><tr><td align="left">Myo-inositol</td><td char="." align="char">0.0691</td><td char="." align="char">0.1330</td></tr><tr><td align="left">Lactic acid</td><td char="." align="char">0.0060</td><td char="." align="char">0.6645</td></tr><tr><td align="left">Pyroglutamic acid</td><td char="." align="char">0.0234</td><td char="." align="char">0.3876</td></tr><tr><td align="left">3,4-Dihydroxybenzoic acid</td><td char="." align="char">0.0810</td><td char="." align="char">0.1029</td></tr><tr><td align="left">Pyridoxine</td><td char="." align="char">0.0449</td><td char="." align="char">0.2291</td></tr><tr><td align="left">Alanine</td><td char="." align="char">0.0006</td><td char="." align="char">0.8891</td></tr><tr><td align="left">Glutamine</td><td char="." align="char">0.0176</td><td char="." align="char">0.4542</td></tr><tr><td align="left">Alanine 2</td><td char="." align="char">0.0000</td><td char="." align="char">0.9853</td></tr></tbody></table></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Summary of Linear Regression Analyses of relationship between significantly changing metabolites and Sequential Organ Failure Assessment (SOFA) score over a 10 day ICU stay. Where two peaks of the same metabolites are seen (representing different isomers) these are numbered separately. “Unknown” refers to metabolites not seein the HMDB.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Metabolite</th><th align="left">R Squared</th><th align="left"><italic>p</italic> value</th></tr></thead><tbody><tr><td align="left">Acetone</td><td char="." align="char">0.0077</td><td char="." align="char">0.4772</td></tr><tr><td align="left">Acetonacetic acid</td><td char="." align="char">0.0173</td><td char="." align="char">0.2848</td></tr><tr><td align="left">3-Hydroxybutyric acid 1</td><td char="." align="char">0.0541</td><td char="." align="char">0.0562</td></tr><tr><td align="left">3-Hydroxybutyric acid 2</td><td char="." align="char">0.0875</td><td char="." align="char">0.0143</td></tr><tr><td align="left">Unknown 6</td><td char="." align="char">0.0507</td><td char="." align="char">0.0648</td></tr><tr><td align="left">Citric acid 2</td><td char="." align="char">0.0071</td><td char="." align="char">0.4949</td></tr><tr><td align="left">Citric acid 4</td><td char="." align="char">0.0048</td><td char="." align="char">0.5760</td></tr><tr><td align="left">Dimethylsulfone</td><td char="." align="char">0.0027</td><td char="." align="char">0.6735</td></tr><tr><td align="left">Carnitine</td><td char="." align="char">0.1397</td><td char="." align="char">0.0017</td></tr><tr><td align="left">Methanol</td><td char="." align="char">0.0028</td><td char="." align="char">0.6682</td></tr><tr><td align="left">2,3-Butandiol</td><td char="." align="char">0.0038</td><td char="." align="char">0.6176</td></tr><tr><td align="left">maltose</td><td char="." align="char">0.0005</td><td char="." align="char">0.8617</td></tr><tr><td align="left">Myo-inositol</td><td char="." align="char">0.0370</td><td char="." align="char">0.1161</td></tr><tr><td align="left">Lactic acid</td><td char="." align="char">0.2018</td><td char="." align="char">0.0001</td></tr><tr><td align="left">Pyroglutamic acid</td><td char="." align="char">0.0127</td><td char="." align="char">0.3609</td></tr><tr><td align="left">3,4-Dihydroxybenzoic acid</td><td char="." align="char">0.0002</td><td char="." align="char">0.9076</td></tr><tr><td align="left">pyridoxine</td><td char="." align="char">0.0746</td><td char="." align="char">0.0243</td></tr><tr><td align="left">Alanine</td><td char="." align="char">0.1131</td><td char="." align="char">0.0050</td></tr><tr><td align="left">Glutamine</td><td char="." align="char">0.0524</td><td char="." align="char">0.0604</td></tr><tr><td align="left">Alanine 2</td><td char="." align="char">0.0067</td><td char="." align="char">0.5056</td></tr></tbody></table></table-wrap></p>
              </sec>
            </sec>
            <sec id="Sec17">
              <title>Discussion</title>
              <p id="Par27">We performed a detailed metabolic analysis of amino acid, lipid and small molecule profiling in response to intermittent enteral feeding compared to continuous enteral feeding in critically ill patients, in the context of a multi-centre randomised controlled trial. We examined these three specific metabolite panels, composed of twenty four amino acid metabolites, nineteen lipid based metabolites and 44 small molecule metabolites over a four hour window within a day and longitudinally up to 10 days, in addition to between arms. No differences were seen between groups at each of the individual time points. Using a mixed effect moderated empirical Bayesian approach, we confirmed this finding, allowing us to collapse the study arms and examine changes over time of specific metabolites. Decreases in relative concentrations of small metabolites related to fatty acid, ketone acid and carbohydrate metabolism were observed over the first 10 days of critical illness.</p>
              <p id="Par28">Metabolic profiling of these critically ill patients was surprisingly stable over time, with alterations only being seen at 10 days as opposed to variations at earlier timepoints. This may reflect the population chosen, as all patients had multi-organ failure, and reach an abnormal equilibrium of cellular metabolism early, and resolve slowly. This is in keeping with our previous observations in skeletal muscle and the limited clinical metabolomics data in critically ill patients<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup><italic>.</italic> These findings were also suprising given the differential recovery of insulin sensitivity between trial arms between day 7 and day 10<sup>5</sup>. While metabolite profiling may discriminate between healthy subjects and patients with insulin resistance in stable settings, insulin resistance is a dynamic phenomenon in the critically ill, and may have attenuated effects on metabolite abundance<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>.</p>
              <p id="Par29">Decreases in circulating glutamine have been well described in the critical care literature, although supplementation is associated with an increase in mortality, perhaps through ammonia generation<sup><xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR33">33</xref></sup>. Reductions in plasma Alanine concentration may reflect an increased throughput of the Cahill cycle to generate Adenosine Tri-Phosphate, in an attempt to redress cellular bioenergetic failure in critical illness<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. Beta-oxidation is impaired in the skeletal muscle critically ill patients, and this may be reflected in the unchanged lipid metabolite concentrations over time, though the degree to whicih appendicular muscles contribute to total energy expenditure in a resting and sedated ICU patient is unclear <sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Decreases in circulating carnitine likely reflect the decrease in intramuscular carnitine pallmitoyltransferase concentrations in critical illness<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Decreases in carbohydrate metabolites likely reflect impaired oxidative phosphorylation which, in combination with impaired beta-oxidation, may result in substrate switching and corresponding ketone body metabolism<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. Increasing severity of organ failure was related to increasing ketone body metabolism, carnitine deficiency and alanine abundance in keeping with the processes described above. The relationship between increasing lactate and illness severity is well described.</p>
              <p id="Par30">2,3-Butandiol is produced from sugar-fermenting microbes (e.g. Klebsiella sp, Entrobacter Sp, Serratia Sp, Bacillus Sp), and the decrease in metabolite levels are likely to reflect dysbiosis of critical illness, of which our understanding is still nascent<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>.</p>
              <p id="Par31">Teasing apart the relationship between these processes across time and determining the true biological significance of the findings remains challenging, and will remain so until experimental and interventional studies can perturb these processes in the critically ill. Our data are the first to demonstrate these changes longitudinally as opposed to across cohorts, strengthening the case for focusing intervention development on these pathways. Metabolite profiling has been used in the past to determine effects of interventions such as Vitamin D<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. In this publication, we separated metabolites into three categories- amino acids, lipids and small molecules, refining metabolite signatures in critical illness. These refinements may be useful in standardising comparisons in metabolite profiling within randomised controlled trials. The ability to compare data across trials is fundamental to evidence synthesis and field development, and as metabolite profiling becomes more commonplace, such standardisations will increase in importance.</p>
              <p id="Par32">We were unable to demonstrate a difference in metabolite patterns between trial arms at individual timepoints. These data suggest that intermittent feeding is unable to sufficiently alter metabolism in critically ill patients, and therefore is unlikely to be better than continuous feeding in affecting end-organ metabolism. This does not, however, rule out the existence of other benefits of intermittent feeding regimens, such as increased nutrition delivery by overcoming difficulties in the process of nutritional delivery to the critically ill patient<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. Intermittent or bolus feeding regimes have not been standardised, and there remains debate on the methodology, and comprehensive reviews exist(ref). The effect on the metabolic outcomes of selecting a different intermittent feeding regimen is unknown Other untested benefits of intermittent feeding regimens include beneficial impacts on autophagy, which periods of intermittent fasting may promote<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. Testing these two hypotheses requires further prospective randomised trials, as does studying the effect of intermittent feeding on circadian rhythms and sleep quality<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. Lastly, the role of coordinated intermittent feeding and exercise regimens needs to be tested in the recovery phase of critical illness, as the two processes are synergistic in stimulation of muscle protein synthesis<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>.</p>
              <p id="Par33">These data represent one of the the largest matrices of metabolomics data in critical illness, as a result of the repeated sampling within days and across 7–10 days which, to our knowledge, has not been performed previously. The multi-centre nature of the trial suggests that these data have significant external validity. Most of the results presented are independent of feeding regimen across length of ICU admission<bold>,</bold> allowing us to use all of the high quality trial biorepository samples to increase study power. This was advantageous as we were unable to pre-determine effect or sample size. These data will inform the design and approach of future studies in critically ill patients, by both enabling a priori statistical plans and a uniform method of handling datasets and longitudinal sampling. The lack of difference in primary outcome measure limited our ability to differentiate reponse/non-response. Muscle metabolite profiling would have been an attractive addition, although this was impractical in the setting of a multi-centre randomised controlled trial. Furthermore, we took advantage of NMR-based metabolic profiling benefits, including non-destructive nature of sample analysis, and the ability to accurately quantitate metabolite levels and to accurately annotate metabolites (an inherent issue for MS) and high level of experimental reproducibility<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Analyses were based on 87 metabolites which is not unusual for NMR studies, with a range of 50 to several hundred being usual on most common platforms<sup><xref ref-type="bibr" rid="CR46">46</xref></sup><italic>.</italic> Future work may benefit from Mass Spectrometry based metabolomics with increased coverage.</p>
            </sec>
            <sec id="Sec18">
              <title>Conclusions</title>
              <p id="Par34">A 6-times per day intermittent feeding regimen did not alter metabolite patterns across time compared to continuous feeding in critically ill patients, within a 24 h period, nor across a 10-day intervention. Future research on intermittent feeding regimens should focus on clinical process benefits, or extended gut rest and fasting.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <sec id="Sec19">
                <title>Supplementary Information</title>
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="41598_2023_46490_MOESM1_ESM.pdf">
                      <caption>
                        <p>Supplementary Information.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <sec>
              <title>Supplementary Information</title>
              <p>The online version contains supplementary material available at 10.1038/s41598-023-46490-5.</p>
            </sec>
            <ack>
              <title>Acknowledgements</title>
              <p>We acknowledge the Centre for Biomolecular Spectroscopy at King’s College London funded by the Wellcome Trust and British Heart Foundation (ref. 202,767/Z/16/Z and IG/16/2/32,273). We are grateful to the staff and patients (and families) at all recruiting centres for their time and support.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contributions</title>
              <p>D.W., P.A., Z.P., S.H. conceived and designed the manuscript. A.M., D.B., H.M., N.H., Z.P. conceived, designed and delivered the original trial. T.F., M.C. A.G., I.G., D.W. performed the analysis. D.W., Z.P., A.M., P.A. wrote the main manuscript. All authors reviewed the manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>HM is supported by the National Institute of Health Research’s Comprehensive Biomedical Research Centre at University College London Hospitals (UCLH NIHR BRC, BRC202 rev/CM/AM/101320; RCF236/AMcN/2015); J P Moulton Charitable Foundation (JM29/04/ 14; JM02/06/15); Intensive Care Foundation (New Investigator Award, A. S. McN.); London South Local Clinical Research Network (LCRN) (D. E. B.: November 2014- May 2015); North Thames LCRN (A. S. McN.: January 2017-March 2017); American Society of Parenteral and Enteral Nutrition Rhoads Research Foundation (Z. A. P.: January 2018-January 2020).</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data availability</title>
              <p>Datasets generated are available on reasonable request to the corresponding author (Z.puthucheary@qmul.ac.uk).</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Code availability</title>
              <p>Code used for analyses is available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.10055412">https://doi.org/10.5281/zenodo.10055412</ext-link>.</p>
            </notes>
            <notes id="FPar1" notes-type="COI-statement">
              <title>Competing interests</title>
              <p id="Par35">This work was supported (in part) by the ASPEN Rhoads Research Foundation. D. E. B. reports speaker fees from, Baxter Healthcare; advisory board fees from Baxter Healthcare;. N. H. reports unrestricted grants from Philips and ResMed outside the direct area of work commented on here with the funds held and managed by Guy’s and St Thomas’ NHS Foundation Trust; financial support from Philips for the development of MYOTRACE technology that has a patent filed in Europe (US pending) outside the area of work commented on here; personal fees for lecturing from Philips-Respironics, Philips, ResMed, and Fisher-Paykel both within and outside the area of work commented on here; N. H. is on the Pulmonary Research Advisory Board for Philips outside the area of work commented on here with the funds for this role held by Guy’s and St Thomas’ NHS Foundation Trust. H. E. M. has a patent, “The Use of Inhibitors of the Renin-Angiotensin System,” which relates in part to the prevention of muscle wasting, issued. Z. A. P. reports personal fees from Faraday Pharmaceuticals, Lyric Pharmaceuticals,Bioage, Fresenius Kabi, Nestlé, Orion, and GlaxoSmithKline, outside the submitted work. 
None declared (DW, IJG, AM,PJA, ALG, MRC, TF, SDR).</p>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arabi</surname>
                      <given-names>YM</given-names>
                    </name>
                    <name>
                      <surname>Casaer</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Chapman</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The intensive care medicine research agenda in nutrition and metabolism</article-title>
                  <source>Intensive Care Med.</source>
                  <year>2017</year>
                  <volume>43</volume>
                  <fpage>1239</fpage>
                  <lpage>1256</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00134-017-4711-6</pub-id>
                  <?supplied-pmid 28374096?>
                  <pub-id pub-id-type="pmid">28374096</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Puthucheary</surname>
                      <given-names>ZA</given-names>
                    </name>
                    <name>
                      <surname>Rawal</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>McPhail</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Acute skeletal muscle wasting in critical illness</article-title>
                  <source>JAMA.</source>
                  <year>2013</year>
                  <volume>310</volume>
                  <issue>15</issue>
                  <fpage>1591</fpage>
                  <lpage>1600</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.2013.278481</pub-id>
                  <?supplied-pmid 24108501?>
                  <pub-id pub-id-type="pmid">24108501</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chapple</surname>
                      <given-names>LS</given-names>
                    </name>
                    <name>
                      <surname>Kouw</surname>
                      <given-names>IWK</given-names>
                    </name>
                    <name>
                      <surname>Summers</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Muscle protein synthesis after protein administration in critical illness</article-title>
                  <source>Am. J. Respir. Crit. Care Med.</source>
                  <year>2022</year>
                  <volume>206</volume>
                  <issue>6</issue>
                  <fpage>740</fpage>
                  <lpage>749</lpage>
                  <pub-id pub-id-type="doi">10.1164/rccm.202112-2780OC</pub-id>
                  <?supplied-pmid 35584344?>
                  <pub-id pub-id-type="pmid">35584344</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Atherton</surname>
                      <given-names>PJ</given-names>
                    </name>
                    <name>
                      <surname>Etheridge</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Watt</surname>
                      <given-names>PW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Muscle full effect after oral protein: Time-dependent concordance and discordance between human muscle protein synthesis and mTORC1 signaling</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>2010</year>
                  <volume>92</volume>
                  <issue>5</issue>
                  <fpage>1080</fpage>
                  <lpage>1088</lpage>
                  <pub-id pub-id-type="doi">10.3945/ajcn.2010.29819</pub-id>
                  <?supplied-pmid 20844073?>
                  <pub-id pub-id-type="pmid">20844073</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McNelly</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Bear</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Connolly</surname>
                      <given-names>BA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of intermittent or continuous feed on muscle wasting in critical illness: A phase 2 clinical trial</article-title>
                  <source>Chest.</source>
                  <year>2020</year>
                  <volume>158</volume>
                  <issue>1</issue>
                  <fpage>183</fpage>
                  <lpage>194</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.chest.2020.03.045</pub-id>
                  <?supplied-pmid 32247714?>
                  <pub-id pub-id-type="pmid">32247714</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bear</surname>
                      <given-names>DE</given-names>
                    </name>
                    <name>
                      <surname>Hart</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Puthucheary</surname>
                      <given-names>Z</given-names>
                    </name>
                  </person-group>
                  <article-title>Continuous or intermittent feeding: Pros and cons</article-title>
                  <source>Current Opin. Crit. Care.</source>
                  <year>2018</year>
                  <volume>24</volume>
                  <issue>4</issue>
                  <fpage>256</fpage>
                  <lpage>261</lpage>
                  <pub-id pub-id-type="doi">10.1097/MCC.0000000000000513</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnston</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Ordovas</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Scheer</surname>
                      <given-names>FA</given-names>
                    </name>
                    <name>
                      <surname>Turek</surname>
                      <given-names>FW</given-names>
                    </name>
                  </person-group>
                  <article-title>Circadian rhythms, metabolism, and chrononutrition in rodents and humans</article-title>
                  <source>Adv. Nutr.</source>
                  <year>2016</year>
                  <volume>7</volume>
                  <issue>2</issue>
                  <fpage>399</fpage>
                  <lpage>406</lpage>
                  <pub-id pub-id-type="doi">10.3945/an.115.010777</pub-id>
                  <?supplied-pmid 26980824?>
                  <pub-id pub-id-type="pmid">26980824</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kamdar</surname>
                      <given-names>BB</given-names>
                    </name>
                    <name>
                      <surname>Needham</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Collop</surname>
                      <given-names>NA</given-names>
                    </name>
                  </person-group>
                  <article-title>Sleep deprivation in critical illness: Its role in physical and psychological recovery</article-title>
                  <source>J. Intensive Care Med.</source>
                  <year>2012</year>
                  <volume>27</volume>
                  <issue>2</issue>
                  <fpage>97</fpage>
                  <lpage>111</lpage>
                  <pub-id pub-id-type="doi">10.1177/0885066610394322</pub-id>
                  <?supplied-pmid 21220271?>
                  <pub-id pub-id-type="pmid">21220271</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chowdhury</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Hoad</surname>
                      <given-names>CL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effects of bolus and continuous nasogastric feeding on gastric emptying, small bowel water content, superior mesenteric artery blood flow, and plasma hormone concentrations in healthy adults: A randomized crossover study</article-title>
                  <source>Ann. Surg.</source>
                  <year>2016</year>
                  <volume>263</volume>
                  <issue>3</issue>
                  <fpage>450</fpage>
                  <lpage>457</lpage>
                  <pub-id pub-id-type="doi">10.1097/SLA.0000000000001110</pub-id>
                  <?supplied-pmid 25549202?>
                  <pub-id pub-id-type="pmid">25549202</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Derde</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Vanhorebeek</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Guiza</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Early parenteral nutrition evokes a phenotype of autophagy deficiency in liver and skeletal muscle of critically ill rabbits</article-title>
                  <source>Endocrinology.</source>
                  <year>2012</year>
                  <volume>153</volume>
                  <issue>5</issue>
                  <fpage>2267</fpage>
                  <lpage>2276</lpage>
                  <pub-id pub-id-type="doi">10.1210/en.2011-2068</pub-id>
                  <?supplied-pmid 22396453?>
                  <pub-id pub-id-type="pmid">22396453</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goel</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Stunkard</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Rogers</surname>
                      <given-names>NL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Circadian rhythm profiles in women with night eating syndrome</article-title>
                  <source>J. Biol. Rhythms.</source>
                  <year>2009</year>
                  <volume>24</volume>
                  <issue>1</issue>
                  <fpage>85</fpage>
                  <lpage>94</lpage>
                  <pub-id pub-id-type="doi">10.1177/0748730408328914</pub-id>
                  <?supplied-pmid 19150931?>
                  <pub-id pub-id-type="pmid">19150931</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhao</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Hutchison</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Heilbronn</surname>
                      <given-names>LK</given-names>
                    </name>
                  </person-group>
                  <article-title>Carbohydrate intake and circadian synchronicity in the regulation of glucose homeostasis</article-title>
                  <source>Current Opin. Clin. Nutr. Metab. Care.</source>
                  <year>2021</year>
                  <volume>24</volume>
                  <issue>4</issue>
                  <fpage>342</fpage>
                  <lpage>348</lpage>
                  <pub-id pub-id-type="doi">10.1097/MCO.0000000000000756</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Puthucheary</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Gunst</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Are periods of feeding and fasting protective during critical illness?</article-title>
                  <source>Current Opin. Clin. Nutr Metab Care.</source>
                  <year>2021</year>
                  <volume>24</volume>
                  <issue>2</issue>
                  <fpage>183</fpage>
                  <lpage>188</lpage>
                  <pub-id pub-id-type="doi">10.1097/MCO.0000000000000718</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Puthucheary</surname>
                      <given-names>ZA</given-names>
                    </name>
                    <name>
                      <surname>Phadke</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Rawal</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Qualitative ultrasound in acute critical illness muscle wasting</article-title>
                  <source>Crit Care Med.</source>
                  <year>2015</year>
                  <volume>43</volume>
                  <issue>8</issue>
                  <fpage>1603</fpage>
                  <lpage>1611</lpage>
                  <pub-id pub-id-type="doi">10.1097/CCM.0000000000001016</pub-id>
                  <?supplied-pmid 25882765?>
                  <pub-id pub-id-type="pmid">25882765</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Orsso</surname>
                      <given-names>CE</given-names>
                    </name>
                    <name>
                      <surname>Montes-Ibarra</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Findlay</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: A scoping review of future research</article-title>
                  <source>J. Cachexia Sarcopenia Muscle.</source>
                  <year>2022</year>
                  <volume>13</volume>
                  <issue>3</issue>
                  <fpage>1442</fpage>
                  <lpage>1459</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcsm.12954</pub-id>
                  <?supplied-pmid 35301816?>
                  <pub-id pub-id-type="pmid">35301816</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Parry</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>El-Ansary</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Cartwright</surname>
                      <given-names>MS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function</article-title>
                  <source>J. Crit. Care.</source>
                  <year>2015</year>
                  <volume>30</volume>
                  <issue>5</issue>
                  <fpage>1151</fpage>
                  <lpage>1159</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jcrc.2015.05.024</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mourtzakis</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Parry</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Connolly</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Puthucheary</surname>
                      <given-names>Z</given-names>
                    </name>
                  </person-group>
                  <article-title>Skeletal muscle ultrasound in critical care: A tool in need of translation</article-title>
                  <source>Ann. Am. Thorac. Soc.</source>
                  <year>2017</year>
                  <volume>14</volume>
                  <issue>10</issue>
                  <fpage>1495</fpage>
                  <lpage>1503</lpage>
                  <pub-id pub-id-type="doi">10.1513/AnnalsATS.201612-967PS</pub-id>
                  <?supplied-pmid 28820608?>
                  <pub-id pub-id-type="pmid">28820608</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aguilar</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Nilsson</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bodenhausen</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>GA</given-names>
                    </name>
                  </person-group>
                  <article-title>Spin echo NMR spectra without J modulation</article-title>
                  <source>Chem. Commun. (Camb).</source>
                  <year>2012</year>
                  <volume>48</volume>
                  <issue>6</issue>
                  <fpage>811</fpage>
                  <lpage>813</lpage>
                  <pub-id pub-id-type="doi">10.1039/C1CC16699A</pub-id>
                  <?supplied-pmid 22143456?>
                  <pub-id pub-id-type="pmid">22143456</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>CS</given-names>
                    </name>
                  </person-group>
                  <article-title>An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses</article-title>
                  <source>J. Magn. Reson. Ser. A</source>
                  <year>1995</year>
                  <volume>115</volume>
                  <issue>2</issue>
                  <fpage>260</fpage>
                  <lpage>264</lpage>
                  <pub-id pub-id-type="doi">10.1006/jmra.1995.1176</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wishart</surname>
                      <given-names>DS</given-names>
                    </name>
                    <name>
                      <surname>Feunang</surname>
                      <given-names>YD</given-names>
                    </name>
                    <name>
                      <surname>Marcu</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>HMDB 4y5.0: The human metabolome database for 2018</article-title>
                  <source>Nucl. Acids Res.</source>
                  <year>2018</year>
                  <volume>46</volume>
                  <issue>D1</issue>
                  <fpage>D608</fpage>
                  <lpage>D617</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkx1089</pub-id>
                  <?supplied-pmid 29140435?>
                  <pub-id pub-id-type="pmid">29140435</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ulrich</surname>
                      <given-names>EL</given-names>
                    </name>
                    <name>
                      <surname>Akutsu</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Doreleijers</surname>
                      <given-names>JF</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>BioMagResBank</article-title>
                  <source>Nucl. Acids Res.</source>
                  <year>2008</year>
                  <volume>36</volume>
                  <issue>Database issue</issue>
                  <fpage>D402</fpage>
                  <lpage>408</lpage>
                  <?supplied-pmid 17984079?>
                  <pub-id pub-id-type="pmid">17984079</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xia</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>DS</given-names>
                    </name>
                  </person-group>
                  <article-title>Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis</article-title>
                  <source>Curr. Protoc. Bioinform.</source>
                  <year>2016</year>
                  <volume>55</volume>
                  <fpage>14</fpage>
                  <pub-id pub-id-type="doi">10.1002/cpbi.11</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xia</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Sinelnikov</surname>
                      <given-names>IV</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Wishart</surname>
                      <given-names>DS</given-names>
                    </name>
                  </person-group>
                  <article-title>MetaboAnalyst 3.0—making metabolomics more meaningful</article-title>
                  <source>Nucl. Acids Res.</source>
                  <year>2015</year>
                  <volume>43</volume>
                  <issue>W1</issue>
                  <fpage>W251</fpage>
                  <lpage>W257</lpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkv380</pub-id>
                  <?supplied-pmid 25897128?>
                  <pub-id pub-id-type="pmid">25897128</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ritchie</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Phipson</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>
                  <source>Nucl. Acids Res.</source>
                  <year>2015</year>
                  <volume>43</volume>
                  <issue>7</issue>
                  <fpage>e47</fpage>
                  <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
                  <?supplied-pmid 25605792?>
                  <pub-id pub-id-type="pmid">25605792</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wickham</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Welcome to the tidyverse</article-title>
                  <source>J. Open Source Softw.</source>
                  <year>2019</year>
                  <volume>4</volume>
                  <issue>43</issue>
                  <fpage>1686</fpage>
                  <pub-id pub-id-type="doi">10.21105/joss.01686</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smyth</surname>
                      <given-names>GK</given-names>
                    </name>
                  </person-group>
                  <article-title>Linear models and empirical bayes methods for assessing differential expression in microarray experiments</article-title>
                  <source>Stat. Appl. Genet. Mol. Biol.</source>
                  <year>2004</year>
                  <pub-id pub-id-type="doi">10.2202/1544-6115.1027</pub-id>
                  <?supplied-pmid 16646809?>
                  <pub-id pub-id-type="pmid">16646809</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnstone</surname>
                      <given-names>IM</given-names>
                    </name>
                    <name>
                      <surname>Titterington</surname>
                      <given-names>DM</given-names>
                    </name>
                  </person-group>
                  <article-title>Statistical challenges of high-dimensional data</article-title>
                  <source>Philos. Trans. A Math. Phys. Eng. Sci.</source>
                  <year>1906</year>
                  <volume>2009</volume>
                  <issue>367</issue>
                  <fpage>4237</fpage>
                  <lpage>4253</lpage>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Christopher</surname>
                      <given-names>KB</given-names>
                    </name>
                  </person-group>
                  <article-title>Nutritional metabolomics in critical illness</article-title>
                  <source>Curr. Opin. Clin. Nutr. Metab. Care.</source>
                  <year>2018</year>
                  <volume>21</volume>
                  <issue>2</issue>
                  <fpage>121</fpage>
                  <lpage>125</lpage>
                  <pub-id pub-id-type="doi">10.1097/MCO.0000000000000451</pub-id>
                  <?supplied-pmid 29251691?>
                  <pub-id pub-id-type="pmid">29251691</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Puthucheary</surname>
                      <given-names>ZA</given-names>
                    </name>
                    <name>
                      <surname>Astin</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>McPhail</surname>
                      <given-names>MJW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Metabolic phenotype of skeletal muscle in early critical illness</article-title>
                  <source>Thorax.</source>
                  <year>2018</year>
                  <volume>73</volume>
                  <issue>10</issue>
                  <fpage>926</fpage>
                  <lpage>935</lpage>
                  <pub-id pub-id-type="doi">10.1136/thoraxjnl-2017-211073</pub-id>
                  <?supplied-pmid 29980655?>
                  <pub-id pub-id-type="pmid">29980655</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lanzi</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Codecasa</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Cornacchia</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fat oxidation, hormonal and plasma metabolite kinetics during a submaximal incremental test in lean and obese adults</article-title>
                  <source>PLoS ONE.</source>
                  <year>2014</year>
                  <volume>9</volume>
                  <issue>2</issue>
                  <fpage>e88707</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0088707</pub-id>
                  <?supplied-pmid 24523934?>
                  <pub-id pub-id-type="pmid">24523934</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heyland</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Muscedere</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Wischmeyer</surname>
                      <given-names>PE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A randomized trial of glutamine and antioxidants in critically ill patients</article-title>
                  <source>N. Engl. J. Med.</source>
                  <year>2013</year>
                  <volume>368</volume>
                  <issue>16</issue>
                  <fpage>1489</fpage>
                  <lpage>1497</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa1212722</pub-id>
                  <?supplied-pmid 23594003?>
                  <pub-id pub-id-type="pmid">23594003</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heyland</surname>
                      <given-names>DK</given-names>
                    </name>
                    <name>
                      <surname>Dhaliwal</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of glutamine supplementation in critical illness given the results of the REDOXS study</article-title>
                  <source>Jpen.</source>
                  <year>2013</year>
                  <volume>37</volume>
                  <issue>4</issue>
                  <fpage>442</fpage>
                  <lpage>443</lpage>
                  <pub-id pub-id-type="doi">10.1177/0148607113488421</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haines</surname>
                      <given-names>RW</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Catabolism in critical illness: A reanalysis of the REDOXS trial</article-title>
                  <source>Crit. Care Med.</source>
                  <year>2022</year>
                  <volume>50</volume>
                  <issue>7</issue>
                  <fpage>1072</fpage>
                  <lpage>1082</lpage>
                  <pub-id pub-id-type="doi">10.1097/CCM.0000000000005499</pub-id>
                  <?supplied-pmid 35220340?>
                  <pub-id pub-id-type="pmid">35220340</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sarabhai</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Roden</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Hungry for your alanine: When liver depends on muscle proteolysis</article-title>
                  <source>J. Clin. Investig.</source>
                  <year>2019</year>
                  <volume>129</volume>
                  <issue>11</issue>
                  <fpage>4563</fpage>
                  <lpage>4566</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI131931</pub-id>
                  <?supplied-pmid 31545302?>
                  <pub-id pub-id-type="pmid">31545302</pub-id>
                </element-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>De Bruyn</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gunst</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Goossens</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of withholding early parenteral nutrition in PICU on ketogenesis as potential mediator of its outcome benefit</article-title>
                  <source>Crit. Care.</source>
                  <year>2020</year>
                  <volume>24</volume>
                  <issue>1</issue>
                  <fpage>536</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13054-020-03256-z</pub-id>
                  <?supplied-pmid 32867803?>
                  <pub-id pub-id-type="pmid">32867803</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Langley</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <name>
                      <surname>Migaud</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Flores</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A metabolomic endotype of bioenergetic dysfunction predicts mortality in critically ill patients with acute respiratory failure</article-title>
                  <source>Sci. Rep.</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <issue>1</issue>
                  <fpage>10515</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-021-89716-0</pub-id>
                  <?supplied-pmid 34006901?>
                  <pub-id pub-id-type="pmid">34006901</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ji</surname>
                      <given-names>XJ</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Ouyang</surname>
                      <given-names>PK</given-names>
                    </name>
                  </person-group>
                  <article-title>Microbial 2,3-butanediol production: A state-of-the-art review</article-title>
                  <source>Biotechnol. Adv.</source>
                  <year>2011</year>
                  <volume>29</volume>
                  <issue>3</issue>
                  <fpage>351</fpage>
                  <lpage>364</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biotechadv.2011.01.007</pub-id>
                  <?supplied-pmid 21272631?>
                  <pub-id pub-id-type="pmid">21272631</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McDonald</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Ackermann</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Khailova</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Extreme dysbiosis of the microbiome in critical illness</article-title>
                  <source>mSphere.</source>
                  <year>2016</year>
                  <volume>1</volume>
                  <issue>4</issue>
                  <fpage>e00199</fpage>
                  <pub-id pub-id-type="doi">10.1128/mSphere.00199-16</pub-id>
                  <?supplied-pmid 27602409?>
                  <pub-id pub-id-type="pmid">27602409</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lasky-Su</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Dahlin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Litonjua</surname>
                      <given-names>AA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Metabolome alterations in severe critical illness and vitamin D status</article-title>
                  <source>Crit. Care.</source>
                  <year>2017</year>
                  <volume>21</volume>
                  <issue>1</issue>
                  <fpage>193</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13054-017-1794-y</pub-id>
                  <?supplied-pmid 28750641?>
                  <pub-id pub-id-type="pmid">28750641</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reid</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Frequency of under- and overfeeding in mechanically ventilated ICU patients: Causes and possible consequences</article-title>
                  <source>J. Hum. Nutr. Diet.</source>
                  <year>2006</year>
                  <volume>19</volume>
                  <issue>1</issue>
                  <fpage>13</fpage>
                  <lpage>22</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1365-277X.2006.00661.x</pub-id>
                  <?supplied-pmid 16448470?>
                  <pub-id pub-id-type="pmid">16448470</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van Dyck</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Casaer</surname>
                      <given-names>MP</given-names>
                    </name>
                    <name>
                      <surname>Gunst</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Autophagy and Its implications against early full nutrition support in critical illness</article-title>
                  <source>Nutr. Clin. Pract.</source>
                  <year>2018</year>
                  <volume>33</volume>
                  <issue>3</issue>
                  <fpage>339</fpage>
                  <lpage>347</lpage>
                  <pub-id pub-id-type="doi">10.1002/ncp.10084</pub-id>
                  <?supplied-pmid 29665131?>
                  <pub-id pub-id-type="pmid">29665131</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Van Dyck</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Vanhorebeek</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Wilmer</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Towards a fasting-mimicking diet for critically ill patients: The pilot randomized crossover ICU-FM-1 study</article-title>
                  <source>Crit. Care (Lond, Engl.).</source>
                  <year>2020</year>
                  <volume>24</volume>
                  <issue>1</issue>
                  <fpage>249</fpage>
                  <pub-id pub-id-type="doi">10.1186/s13054-020-02987-3</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jamshed</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Beyl</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Della Manna</surname>
                      <given-names>DL</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>ES</given-names>
                    </name>
                    <name>
                      <surname>Ravussin</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Peterson</surname>
                      <given-names>CM</given-names>
                    </name>
                  </person-group>
                  <article-title>Early time-restricted feeding improves 24-h glucose levels and affects markers of the circadian clock, aging, and autophagy in humans</article-title>
                  <source>Nutrients.</source>
                  <year>2019</year>
                  <volume>11</volume>
                  <issue>6</issue>
                  <fpage>1234</fpage>
                  <pub-id pub-id-type="doi">10.3390/nu11061234</pub-id>
                  <?supplied-pmid 31151228?>
                  <pub-id pub-id-type="pmid">31151228</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pickel</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Sung</surname>
                      <given-names>HK</given-names>
                    </name>
                  </person-group>
                  <article-title>Feeding rhythms and the circadian regulation of metabolism</article-title>
                  <source>Front. Nutr.</source>
                  <year>2020</year>
                  <volume>7</volume>
                  <fpage>39</fpage>
                  <pub-id pub-id-type="doi">10.3389/fnut.2020.00039</pub-id>
                  <?supplied-pmid 32363197?>
                  <pub-id pub-id-type="pmid">32363197</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kumar</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Atherton</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Rennie</surname>
                      <given-names>MJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Human muscle protein synthesis and breakdown during and after exercise</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2009</year>
                  <volume>106</volume>
                  <issue>6</issue>
                  <fpage>2026</fpage>
                  <lpage>2039</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.91481.2008</pub-id>
                  <?supplied-pmid 19164770?>
                  <pub-id pub-id-type="pmid">19164770</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Emwas</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Roy</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>McKay</surname>
                      <given-names>RT</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>NMR spectroscopy for metabolomics research</article-title>
                  <source>Metabolites</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <issue>7</issue>
                  <fpage>123</fpage>
                  <pub-id pub-id-type="doi">10.3390/metabo9070123</pub-id>
                  <?supplied-pmid 31252628?>
                  <pub-id pub-id-type="pmid">31252628</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
